AIM, the International Association of Mutual Benefit Societies, has articulated a set of recommendations to rebalance pharmaceutical markets in Europe.

AIM calls for the European Pharmaceutical Strategy to be first and foremost a health strategy to support universal healthcare coverage. It must be a strategy that shapes a pharmaceutical industry for solidarity and sustainable healthcare in Europe.

The recommendations are available here.